-
Posted: January 25th, 2023, 3:00pm GMT
Condition: Cholangiocarcinoma
Interventions: Drug: Carrelizumab; Drug: Solfantinib
Sponsor: First Affiliated Hospital Xi'an Jiaotong University
Not yet recruiting
-
Posted: January 23rd, 2023, 3:00pm GMT
Condition: Cholangiocarcinoma
Intervention:
Sponsor: Power Life Sciences Inc.
Not yet recruiting
-
Posted: January 12th, 2023, 3:00pm GMT
Conditions: Hepatocellular Carcinoma; Fibrolamellar Hepatocellular Carcinoma; Cholangiocarcinoma, Perihilar; Intrahepatic Cholangiocarcinoma; Metastasis to Liver; Gallbladder Carcinoma
Intervention: Other: ADBoard
Sponsors: Charite University, Berlin, Germany; German Research Center for Artificial Intelligence
Not yet recruiting
-
Posted: January 11th, 2023, 3:00pm GMT
Condition: Esophageal Neoplasms
Intervention: Diagnostic Test: KCNA3 and OTOP2 Gene Methylation Combined Detection Kit (Fluorescent PCR Method)
Sponsors: Wuhan Ammunition Life-tech Co., Ltd; Changhai Hospital
Not yet recruiting
-
Posted: January 10th, 2023, 3:00pm GMT
Condition: Locally Advanced Cholangiocarcinoma
Intervention:
Sponsor: CHA University
Not yet recruiting
-
Posted: January 10th, 2023, 3:00pm GMT
Condition: Intrahepatic Cholangiocarcinoma (ICC)
Intervention: Drug: ICP-192
Sponsor: Beijing InnoCare Pharma Tech Co., Ltd.
Recruiting
-
Posted: January 10th, 2023, 3:00pm GMT
Conditions: Hilar Cholangiocarcinoma; Intrahepatic Cholangiocarcinoma; Common Bile Duct Neoplasms; Cholangiocarcinoma; Adenocarcinoma
Intervention: Procedure: Endoscopic Ultrasound registration
Sponsor: Erasmus Medical Center
Recruiting
-
Posted: January 5th, 2023, 3:00pm GMT
Conditions: Durvalumab; Intrahepatic Cholangiocarcinoma; Gemcis
Interventions: Drug: Durvalumab; Procedure: Surgery; Drug: Gemcitabine; Drug: Cisplatin
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Recruiting
-
Posted: December 19th, 2022, 3:00pm GMT
Conditions: Bile Duct Cancer; Cholangiocarcinoma; Cholangiocarcinoma Non-resectable; Cholangiocarcinoma Metastatic; Metastatic Intrahepatic Cholangiocarcinoma
Interventions: Drug: Gemcitabine; Drug: Cisplatin; Drug: Durvalumab; Radiation: Yttrium-90
Sponsors: Dana-Farber Cancer Institute; AstraZeneca; Sirtex Medical
Not yet recruiting
-
Posted: December 16th, 2022, 3:00pm GMT
Condition: Cholangiocarcinoma
Interventions: Drug: Carrilizumab; Drug: Albumin-bound paclitaxel; Drug: Apatinib
Sponsor: First Affiliated Hospital Xi'an Jiaotong University
Not yet recruiting
-
Posted: March 18th, 2022, 2:00pm GMT
Conditions: Metastatic Colorectal Cancer (Mcrc); Intrahepatic Cholangiocarcinoma (Icc); Colorectal Cancer; Colorectal Neoplasms; Cholangiocarcinoma; Intrahepatic Bile Duct Cancer; Bile Duct Cancer; Bile Duct Neoplasms
Interventions: Drug: Floxuridine; Drug: 5-Fluorouracil; Drug: Irinotecan; Device: Intera 3000 Hepatic Artery Infusion Pump (HAIP); Drug: Oxaliplatin; Drug: Leucovorin; Drug: M9241; Drug: Gemcitabine; Drug: Dexamethasone
Sponsor: National Cancer Institute (NCI)
Recruiting
-
Posted: February 16th, 2022, 3:00pm GMT
Conditions: Solid Tumor, Adult; Intrahepatic Cholangiocarcinoma; Urothelial Carcinoma
Intervention: Drug: KIN-3248
Sponsor: Kinnate Biopharma
Recruiting
-
Posted: August 11th, 2021, 2:00pm GMT
Conditions: Bile Duct Cancer; Gall Bladder Cancer; Breast Cancer; Neuroendocrine Tumors; Ovarian Cancer; Pancreatic Adenocarcinoma; Soft Tissue Sarcoma; Vulvar Cancer; Prostate Cancer
Interventions: Drug: Atezolizumab; Drug: Tivozanib
Sponsors: University of Florida; Genentech, Inc.; Aveo Oncology Pharmaceuticals
Recruiting
-
Posted: December 14th, 2020, 3:00pm GMT
Conditions: Metastatic Cancer; Solid Tumor; Pancreatic Cancer; Urothelial Carcinoma; Head and Neck Cancer; Colorectal Cancer
Interventions: Drug: LYT-200; Drug: Tislelizumab; Drug: Gemcitabine/nab-paclitaxel
Sponsor: PureTech
Recruiting
-
Posted: September 28th, 2020, 2:00pm GMT
Conditions: Bile Duct Cancer; Biliary Cancer; Biliary Tract Neoplasms; Cholangiocarcinoma
Interventions: Drug: Trametinib; Drug: Hydroxychloroquine
Sponsor: National Cancer Institute (NCI)
Recruiting
-
Posted: September 23rd, 2020, 2:00pm GMT
Conditions: Biliary Tract Cancer; Cholangiocarcinoma; Gallbladder Cancer; Intrahepatic Cholangiocarcinoma; Perihilar Cholangiocarcinoma; Extrahepatic Cholangiocarcinoma; Hilar Cholangiocarcinoma; Distal Bile Duct Cancer
Intervention: Diagnostic Test: Multi-Platform Profiling with Organoid Drug Sensitivity Screening and ctDNA Monitoring
Sponsors: University of Washington; Natera, Inc.; SEngine Precision Medicine, Inc.
Recruiting
-
Posted: October 30th, 2019, 2:00pm GMT
Conditions: Hepatocellular Carcinoma; Liver Cancer; Cholangiocarcinoma
Intervention:
Sponsor: National Cancer Institute (NCI)
Recruiting
-
Posted: September 12th, 2019, 2:00pm GMT
Condition: Intrahepatic Cholangiocarcinoma
Intervention: Drug: derazantinib
Sponsor: Basilea Pharmaceutica
Available
-
Posted: April 23rd, 2019, 2:00pm GMT
Conditions: Metastatic Breast Carcinoma; Locally Advanced Breast Cancer; Cancer of Pancreas; Solid Tumor With Intermediate or High HER2 Expression; Salivary Gland Cancer; Gastric Cancer; Endometrial Cancer; Uterine Cancer; Non Small Cell Lung Cancer; Biliary Tract Cancer; Cholangiocarcinoma; Colorectal Cancer; Urothelial Carcinoma; Prostate Cancer
Intervention: Drug: 68GaNOTA-Anti-HER2 VHH1
Sponsors: Universitair Ziekenhuis Brussel; Kom Op Tegen Kanker; Agentschap voor Innovatie door Wetenschap en Technologie, Project Toegepast Biomedisch onderzoek met een primair Maatschappelijke finaliteit.
Recruiting
-
Posted: December 11th, 2015, 3:00pm GMT
Conditions: Advanced Cancer; Anal Carcinoma; Anal Cancer; Biliary Cancer; Cholangiocarcinoma; Bile Duct Cancer; Neuroendocrine Tumor; Carcinoid Tumor; Endometrial Carcinoma; Endometrial Cancer; Cervical Carcinoma; Cervical Cancer; Vulvar Carcinoma; Vulvar Cancer; Small Cell Lung Carcinoma; Small Cell Lung Cancer (SCLC); Mesothelioma; Thyroid Carcinoma; Thyroid Cancer; Salivary Gland Carcinoma; Salivary Gland Cancer; Salivary Cancer; Parotid Gland Cancer; Advanced Solid Tumors; Colorectal Carcinoma
Intervention: Biological: pembrolizumab
Sponsor: Merck Sharp & Dohme LLC
Recruiting